Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sollers reported for 3 months of 2024 by RAS

4/23/24 SVAV

Yandex will invest ₽5 billion in a warehouse complex in Tatarstan

4/23/24 YNDX

Lenzoloto reported for 2023 by IFRS

4/23/24 LNZL

UAC reports for 3 months of 2024 by RAS

4/23/24 UNAC

Zaimer reported for the 3 months of 2024 by RAS

4/23/24 ZAYM

AESK reported for 2023 by IFRS

4/23/24 ASSB

Severstal reported for 3 months of 2024 by IFRS

4/23/24 CHMF

Severstal's sales in Q1 decreased by 11%

4/23/24 CHMF

Board of Directors of Severstal recommended dividends

4/23/24 CHMF

Inter RAO to buy back 3% of its shares from an unnamed minority shareholder

4/23/24 IRAO